Scandinavian ChemoTech AB (publ) (STO:CMOTEC.B)
Sweden · Delayed Price · Currency is SEK 3.750
+0.060 (1.63%)
Jul 3, 2026, 2:48 PM CET
Scandinavian ChemoTech AB Company Description
Scandinavian ChemoTech AB (publ), a medical technology company, engages in the development of patented treatment alternatives for humans and animals with cancer in Sweden and internationally.
It offers IQwave, an electroporation that generates tumor-specific electrical stimulation for the treatment of solid superficial tumors of various sizes and locations.
The company was incorporated in 2013 and is headquartered in Lund, Sweden.
Scandinavian ChemoTech AB (publ)
| Country | Sweden |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | Stefan Frick |
Contact Details
Address: Medicon Village Lund, 223 63 Sweden | |
| Phone | 46 1 02 18 93 00 |
| Website | chemotech.se |
Stock Details
| Ticker Symbol | CMOTEC.B |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0009242654 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Stefan Mohan Frick | Founder, Chief Executive Officer, President and Director |
| Ann Ohlsson | Head of Finance |